期刊文献+

多囊卵巢综合征患者并发子宫内膜增生症的临床研究 被引量:4

The clinical study of polycystic ovary syndrome complicated with endometrial hyperplasia
下载PDF
导出
摘要 目的:探讨多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者并发子宫内膜增生症(endometrial hyperplasia,EH)的患病率、病理类型、高危因素及超声检查在筛查该并发症的作用和临床转归。方法:根据是否合并EH将440例PCOS患者分为组1(合并EH组,n=18)和组2(非EH组,n=422),比较2组的一般特征、月经失调的类型、超声指标、生殖内分泌激素和糖代谢,随访治疗后子宫内膜的病理改变。结果:PCOS患者并发EH的发病率为4.1%,简单型和复杂型17例(94.44%),不典型1例(5.45%);月经失调类型中,表现为功血者发生EH的风险大于其它类型月经失调(P<0.01,拟然比为21.47),表现为月经稀发继发闭经者发生EH的风险小于其它类型月经失调(P<0.05,拟然比6.282)。组1的年龄及相应病程大于组2(28.82±6.80岁vs23.05±5.32岁,12.42±7.13年vs7.28±5.65年,P<0.01);组1的子宫内膜厚度大于组2(11.75±4.77mmvs7.72±3.14mm,P<0.01),组1子宫内膜异常回声高于组2(100%vs0.47%,P<0.01),子宫动脉的搏动指数和阻力指数低于组2(1.68±0.54vs2.85±1.98,0.77±0.08vs0.88±0.27,P<0.01);两组FSH、LH、LH/FSH、总睾酮和游离雄激素指数的差别没有统计学意义,但组1的性激素结合蛋白低于组2(82.94±41.80mmol/Lvs128.17±117.21mmol/L,P<0.01);两组空腹胰岛素、胰岛素释放试验的曲线下面积、空腹血糖、葡萄糖耐量试验的曲线下面积和稳态模型的胰岛素抵抗指数的差异无统计学意义(P>0.05);治疗后子宫内膜均转化为正常。结论:PCOS患者合并EH的临床转归良好,超声检查在PCOS患者并发EH筛查中有重要作用。 Objective : To investigate the incidence, pathological subtype, high risk factors, ultrasonographic examination, clinical outcome of polycystic ovary syndrome (PCOS) complicated with endometrial hyperplasia(EH). Method:Four hundred and forty cases with PCOS were divided into group 1 (18 cases complicated with endometrial hyperplasia) and group 2 (422 cases without EH). The general characteristic, menstrual history, ultrasonographically in-hood 6. 282). Old age,long history of irregular menstrual cycles, heavy thickness of endometriurn,abnormal uhrasonographical estimation of endometrium,low pulse index and resistant index of uterus arteria were existed in group 1 compared with group 2 (28.82±6.80 vs 23.05±5.32, 12.42±7.13 vs 7.28±5.65 year, 11.75±4.77 vs 7.72±3.14mm, 100% vs 0.47% , 1.68±0. 54 vs 2.85±1.98,0.77±0.08 vs 0.88±0.27 ,respectivelly,P〈0.01 ). There was no statistically difference in LH, LH/FSH ratio, total testosterone and free androgen index( P〉0.05 ), though sexual hormone binding globulin was lower in group in (82.94±41.80 vs 128. 17± 117.21 mmol/L, P〈0. 01 ). Also no statistically difference were found in fasting plasm insulin and insulin area under curve, fasting plasm glucose and glucose area under curve, the HOMA-IR between two groups. The hyperplasia endometrium were Change to normal after therapy. Conclu- sion:Compared with women without EH,PCOS patient with EH has a good outcome measured by clinical prognosis. Ultrasonographically examination has an important role in predicting EH in PCOS.
出处 《现代妇产科进展》 CSCD 北大核心 2009年第9期687-690,共4页 Progress in Obstetrics and Gynecology
关键词 多囊卵巢综合征 子宫内膜增生症 超声检查 Polycystic ovary syndrome Ultrasonography Endometrial hyperplasia
  • 相关文献

参考文献12

  • 1Elliott JL, Hosford SL, Demopoulos RL, et al. Endometrial adenocarcinoma and polycystic ovary syndrome:risk factors, management, and prognosis [ J ]. South Med, 2001, 94:529-531.
  • 2The Rotterdam ESHRE/ASRM-Sponsored PCOS consen sus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [ J]. Hum Reprod ,2004,19:41 - 47.
  • 3World Health Organization, Kurman RJ. Blaustein's Pathology of the Female Genital Tract [ M ]. 5th ed. New Youk : Spring-Verlag, 2002 : 467-500.
  • 4Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, et al. Prevalence and clinical predictors of endometrial hyperplasia in anovulatory women presenting with amenorrhea[ J]. Gynecol Endocrinol,2006,22 : 101-105.
  • 5Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome [ J]. Obstet Gynecol,2001,98 :325-331.
  • 6Reed SD, Newton KM, Clinton WL, et al. Incidence of endometrial hyperplasia [ J ] Am J Obstet Gynecol, 2009, 200:678. e1 -678. e6.
  • 7Farquhar CM, Lethaby A, Sowter M, et al. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding [ J ]. Am J Obstet Gynecol, 1999,181 : 525-529.
  • 8Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with post menopausal bleeding--a Nordic muhicenter study[ J]. Am J Obstet Gynecol, 1995,172 : 1488-1494.
  • 9American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists : number 41, December 2002 [ J ]. Obstet Gynecol,2002,100 : 1389-1402.
  • 10Villavicencio A, Bacallao K, Avellaira C, et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia[ J]. Gynecol Oncol, 2006,103:307-314.

同被引文献33

  • 1姜艳华,孙立新,陈咏健,李美芝.胰岛素及其受体与人类子宫内膜异常增生的关系22例分析[J].中国实用妇科与产科杂志,2005,21(12):755-756. 被引量:2
  • 2张慧英,宋学茹,韩玉崑,薛凤霞,杨振艳.多囊卵巢综合征患者的子宫内膜病理状态分析[J].中华妇产科杂志,2007,42(7):493-494. 被引量:9
  • 3李家泰.临床药物学[M].第2版.北京:人民卫生出版社,2007:1690-1697.
  • 4North American Society for Pediatric and Adolescent Gynecology.Dysfunction uterine bleeding in adolescents[J]. J Pediatr Adolesc Gynecol, 2006, 19 ( 1 ): 49-51.
  • 5The Rotterdam ESHRE/ASRM2Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome ( PCOS )[J]. Hum Rep Rod,2004,19( 1 ): 41-47.
  • 6Higham JM,O' Brien PM, Shaw BW. Assessment of menstrual blood loss using a pictorial chart [J]. BrJ Obstet Gynecol, 1990, 97 ( 8 ) : 734-739.
  • 7Verit FF.High sensitive serum C-reactive protein and its relation- ship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome[J].Arch Gynecol Obstet, 2010, 281 (6):1009-1014.
  • 8Aruna j, Mittal S, Kumar S,etal.Metformin therapy in women with polycystic ovary syndrome [J].Int J Gynaecol Obstet,2004,87(3): 237-241.
  • 9Luque-Ram i rez M, Alvarez-Blasco F, Uriol Rivera MG.etal. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethi- nyl-estradiol plus cyproterone acetate versus metformin [J].Hum Reprod, 2008,23(7):1594-1601.
  • 10Luque-Ram i rez M, Alvarez-Blasco F, Botella-Carretero JI,etal. Increased body iron stores of obese women with polycystic ovary syn- drome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses [J].Diabetes Care,2007,30(9): 2309-2313.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部